Vivus cuts U.S. deal for erectile dysfunction drug
October 11, 2013 at 13:36 PM EDT
An erectile dysfunction drug from Vivus Inc. — approved 1-1/2 years ago but never sold in the United States — will land the Mountain View-based company a $30 million upfront payment from a licensing deal with Auxilium Pharmaceuticals Inc...
